XTL Biopharmaceuticals' IPO

XTL Biopharmaceuticals raised a round of funding on September 27, 2000. Investors include Public.

XTL Biopharmaceuticals focuses on the acquisition and development of late-stage pharmaceutical product candidates for the treatment of unmet clinical needs.…

Articles about XTL Biopharmaceuticals' IPO: